Lobbying client

CHARLES RIVER LABORATORIES

Pharmaceutical Company

The register keeps a separate record of this client for every firm that files for it and every spelling of its name. All 4 of its records are shown together here.

Filings
60
Filed by
4
Reported in-house
—
Reported by firms
$2,030,000

Reported lobbying by year

The larger of in-house and firm-reported each year, $ thousands 2007 to 2026

Filings

60 filings, newest first.
Filing Filed by Amount
1st Quarter - Termination (No Activity)
1st Quarter 2026
BGR GOVERNMENT AFFAIRS — reported
4th Quarter - Report
4th Quarter 2025
BGR GOVERNMENT AFFAIRS $90,000 reported
3rd Quarter - Report
3rd Quarter 2025
BGR GOVERNMENT AFFAIRS $90,000 reported
2nd Quarter - Report
2nd Quarter 2025
BGR GOVERNMENT AFFAIRS $90,000 reported
1st Quarter - Report
1st Quarter 2025
BGR GOVERNMENT AFFAIRS $90,000 reported
4th Quarter - Report
4th Quarter 2024
BGR GOVERNMENT AFFAIRS $90,000 reported
3rd Quarter - Report
3rd Quarter 2024
BGR GOVERNMENT AFFAIRS $90,000 reported
2nd Quarter - Report
2nd Quarter 2024
BGR GOVERNMENT AFFAIRS $90,000 reported
1st Quarter - Report
1st Quarter 2024
BGR GOVERNMENT AFFAIRS $90,000 reported
4th Quarter - Report
4th Quarter 2023
BGR GOVERNMENT AFFAIRS $90,000 reported

Filed by

Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.

Issues lobbied

How many report sections named each issue, counting the current version of each report.

IssueCodeMentions
Animals ANI 30
Medical/Disease Research/Clinical Labs MED 22
Pharmacy PHA 14
Health Issues HCR 14
Transportation TRA 1

Bills named in its filings

Bill numbers found in the filers' descriptions, most often named first.

BillCongressTimes named
H.R. 2419 110th 3

From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.